Related Experiment Video

Updated: Feb 24, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.9K

Immunotherapy for metastatic prostate cancer: immuno-cold or the tip of the iceberg?

Andrew L Laccetti1, Sumit K Subudhi

  • 1aDepartment of Cancer Medicine bDepartment of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Current Opinion in Urology
|August 22, 2017
PubMed
Abstract

Insights

Prostate cancer immunotherapy is advancing with new vaccines and combination strategies. Research is ongoing to improve patient selection and treatment effectiveness for metastatic castration-resistant prostate cancer.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Therapeutics

Background:

  • Metastatic castration-resistant prostate cancer (mCRPC) requires novel treatment approaches.
  • The field of prostate cancer immunotherapy has seen significant evolution since sipuleucel-T's approval.
  • Vaccine and immune checkpoint therapies are key areas of investigation.

Purpose of the Study:

  • To review the current landscape of prostate cancer immunotherapy.
  • To highlight advancements in cancer vaccines and immune checkpoint inhibitors.
  • To discuss emerging combinatorial strategies and future directions.

Main Methods:

  • Review of recent clinical trial data and scientific literature.
  • Analysis of approved therapies and investigational agents.
  • Exploration of novel targets and predictive biomarkers.

Main Results:

  • Sipuleucel-T is the only approved therapeutic cancer vaccine for mCRPC, demonstrating survival benefit.
  • Prostate-specific antigen-TRICOM peptide vaccine shows promise; combinatorial vaccine strategies are emerging.
  • Immune checkpoint therapies (ipilimumab, PD-1 blockade) have shown limited efficacy in prostate cancer.
  • Research is focused on novel targets, combination therapies, and predictive biomarkers for response and toxicity.

Conclusions:

  • Prostate cancer immunotherapy is progressing steadily.
  • Development of novel cancer vaccines, immune checkpoint therapies, and combination strategies is ongoing.
  • Improved patient selection and safety are anticipated through biomarker research.

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

920
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K